Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06621979 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT06621979
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have had a type of weight loss surgery called a one anastomosis gastric bypass, followed by a procedure called fundoplication (a surgery to treat severe acid reflux using the excluded part of the stomach), within the 2 years before joining the study
  • People whose acid reflux has not been controlled with medication alone
  • People who have lost more than 50% of their excess body weight after surgery
  • People who have had specific pre-surgery tests to confirm acid reflux, including a camera examination of the stomach and bowel, an acid and flow measurement test, and a CT scan of the abdomen
  • People who, in the opinion of the study team, are able to understand study information and complete quality-of-life questionnaires
  • People who are willing to take part in all study assessments
  • Women of childbearing age who either have a negative blood pregnancy test or are using effective contraception for the full duration of the study
  • People who have been fully informed about the study and have signed a written consent form

Who may not be able to join:

  • People whose one anastomosis gastric bypass was converted to a different type of bypass surgery (Y bypass) because of severe acid reflux requiring surgery
  • People who had a hiatal hernia repair done at the same time as their one anastomosis gastric bypass
  • People who had a one anastomosis gastric bypass performed as a second or revision weight loss surgery
  • People who have an uncontrolled or irregular diet
  • People who are under legal protection or whose freedom has been restricted by a court or administrative order
  • People who are unable to understand the study information due to language, psychological, cognitive, or other reasons
  • Women who are pregnant, may become pregnant without using effective contraception, or who are currently breastfeeding
  • People who are already taking part in another clinical trial, or who are in an exclusion period from a previous trial that could affect this study's results
  • People who are not covered by a social security (health insurance) scheme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0562132758

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Registry
ClinicalTrials.gov
Start date
24 November 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Response rate after Fundoplicature with stomach excluded

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov